73124 Federal Register / Vol. 89, No. 174 / Monday, September 9, 2024 / Notices 

Zugoo Import Inc., 6670 Jones Mill 

Court, Suite C, Norcross, Georgia 

30092. 

(c) The Office of Unfair Import 

Investigations, U.S. International Trade 

Commission, 500 E Street, SW Suite 

401, Washington, DC 20436; and 

(4) For the investigation so instituted, 

the Chief Administrative Law Judge, 

U.S. International Trade Commission, 

shall designate the presiding 

Administrative Law Judge. 

Responses to the complaint and the 

notice of investigation must be 

submitted by the named respondents in 

accordance with section 210.13 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.13. Pursuant to 

19 CFR 201.16(e) and 210.13(a), as 

amended in 85 FR 15798 (March 19, 

2020), such responses will be 

considered by the Commission if 

received not later than 20 days after the 

date of service by the complainant of the 

complaint and the notice of 

investigation. Extensions of time for 

submitting responses to the complaint 

and the notice of investigation will not 

be granted unless good cause therefor is 

shown. 

Failure of a respondent to file a timely 

response to each allegation in the 

complaint and in this notice may be 

deemed to constitute a waiver of the 

right to appear and contest the 

allegations of the complaint and this 

notice, and to authorize the 

administrative law judge and the 

Commission, without further notice to 

the respondent, to find the facts to be as 

alleged in the complaint and this notice 

and to enter an initial determination 

and a final determination containing 

such findings, and may result in the 

issuance of an exclusion order or a cease 

and desist order or both directed against 

the respondent. 

By order of the Commission. 

Issued: September 4, 2024. 

Sharon Bellamy, 

Supervisory Hearings and Information 

Officer. 

[FR Doc. 2024–20275 Filed 9–6–24; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1423] 

Bulk Manufacturer of Controlled 

Substances Application: Curia New 

York, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Curia New York, Inc. has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

Supplementary Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before November 8, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before November 8, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on August 6, 2024, Curia 

New York, Inc., 33 Riverside Avenue, 

Rensselaer, New York 12144–2951, 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug code Schedule 

Gamma Hydroxybutyric Acid ....................................................................................................................................... 2010 I 

Marihuana .................................................................................................................................................................... 7360 I 

Tetrahydrocannabinols ................................................................................................................................................ 7370 I 

Amphetamine ............................................................................................................................................................... 1100 II 

Lisdexamfetamine ........................................................................................................................................................ 1205 II 

Methylphenidate ........................................................................................................................................................... 1724 II 

Pentobarbital ................................................................................................................................................................ 2270 II 

4-Anilino-N-Phenethyl-4-Piperidine (ANPP) ................................................................................................................ 8333 II 

Codeine ........................................................................................................................................................................ 9050 II 

Oxycodone ................................................................................................................................................................... 9143 II 

Hydromorphone ........................................................................................................................................................... 9150 II 

Hydrocodone ................................................................................................................................................................ 9193 II 

Meperidine ................................................................................................................................................................... 9230 II 

Morphine ...................................................................................................................................................................... 9300 II 

Fentanyl ....................................................................................................................................................................... 9801 II 

The company plans to manufacture 

the above listed controlled substances as 

bulk active pharmaceutical ingredients 

for use in product development and for 

distribution to its customers. 

In reference to drug codes 7360 

(Marihuana), and 7370 

(Tetrahydrocannabinols), the company 

plans to bulk manufacture these drugs 

as synthetic. No other activities for these 

drug codes are authorized for this 

registration. 

Marsha L. Ikner, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2024–20193 Filed 9–6–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1424] 

Importer of Controlled Substances 

Application: Curia New York, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 174 / Monday, September 9, 2024 / Notices 73125 

SUMMARY: Curia New York, Inc. has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to Supplementary 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before October 9, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before October 9, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on August 6, 2024, Curia 

New York, Inc., 33 Riverside Avenue, 

Rensselaer, New York 12144, applied to 

be registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug code Schedule 

Gamma Hydroxybutyric Acid ....................................................................................................................................... 2010 I 

ANPP (4-Anilino-N-phenethyl-4-piperidine) ................................................................................................................. 8333 II 

Poppy Straw Concentrate ............................................................................................................................................ 9670 II 

The company plans to import the 

listed controlled substances for bulk 

manufacturing into other controlled 

substances to be distributed to their 

customers. No other activities for these 

drug codes are authorized for this 

registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Marsha L. Ikner, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2024–20192 Filed 9–6–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF LABOR 

Employment and Training 

Administration 

Labor Surplus Area Classification 

AGENCY: Employment and Training 

Administration, Labor. 

ACTION: Notice. 

SUMMARY: The purpose of this notice is 

to announce the annual Labor Surplus 

Area (LSA) list for fiscal year (FY) 2025. 

DATES: The annual LSA list is effective 

October 1, 2024, for all States, the 

District of Columbia, and Puerto Rico. 

FOR FURTHER INFORMATION CONTACT: 

Lucas Arbulu or Donald Haughton, 

Office of Workforce Investment, 

Employment and Training 

Administration, 200 Constitution 

Avenue NW, Room C–4514, 

Washington, DC 20210. Telephone: 

Lucas Arbulu (202) 693–2611 (this is 

not a toll-free number), or Donald 

Haughton (202) 693–2784 (this is not a 

toll-free number), or email 

arbulu.lucas.w@dol.gov, or 

haughton.donald.w@dol.gov. 

SUPPLEMENTARY INFORMATION: The 

Department of Labor’s regulations 

implementing Executive Orders 12073 

and 10582 are set forth at 20 CFR part 

654, subpart A. These regulations 

require the Employment and Training 

Administration (ETA) to classify 

jurisdictions as LSAs pursuant to the 

criteria specified in the regulations, and 

to publish annually a list of LSAs. 

Pursuant to those regulations, ETA is 

hereby publishing the annual LSA list. 

In addition, the regulations provide 

exceptional circumstance criteria for 

classifying LSAs when catastrophic 

events, such as natural disasters, plant 

closings, and contract cancellations are 

expected to have a long-term impact on 

labor market area conditions, 

discounting temporary or seasonal 

factors. 

Eligible Labor Surplus Areas 

A LSA is a civil jurisdiction that has 

a civilian average annual 

unemployment rate during the previous 

two calendar years of 20 percent or 

more above the average annual civilian 

unemployment rate for all states during 

the same 24-month reference period. 

ETA uses only official unemployment 

estimates provided by the Bureau of 

Labor Statistics in making these 

classifications. The average 

unemployment rate for all states 

includes data for the District of 

Columbia, and the Commonwealth of 

Puerto Rico. The LSA classification 

criteria stipulate a civil jurisdiction 

must have a ‘‘floor unemployment rate’’ 

of 6 percent or higher to be classified an 

LSA. Any civil jurisdiction that has a 

‘‘ceiling unemployment rate’’ of 10 

percent or higher is classified an LSA. 

Civil jurisdictions are defined as 

follows: 

1. A city of at least 25,000 population 

on the basis of the most recently 

available estimates from the Bureau of 

the Census; or 

2. A town or township in the States 

of Michigan, New Jersey, New York, or 

Pennsylvania of 25,000 or more 

population and which possess powers 

and functions similar to those of cities; 

or 

3. All counties, except for those 

counties which contain any type of civil 

jurisdictions defined in ‘‘1’’ or ‘‘2’’ 

above; or 

4. A ‘‘balance of county’’ consisting of 

a county less any component cities and 

townships identified in ‘‘1’’ or ‘‘2’’ 

above; or 

5. A county equivalent which is a 

town in the States of Connecticut, 

Maine, Massachusetts, New Hampshire, 

Rhode Island, Vermont or a municipio 

in the Commonwealth of Puerto Rico. 


ddrumheller on DSK120RN23PROD with NOTICES1